Microbiome Market Trends 2025–2029: Forecasts for Key Growth Segments
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Microbiome Industry Compare Between 2025 And 2029?
The microbiome market has seen substantial growth in recent years. It is anticipated to increase from $0.68 billion in 2024 to $0.82 billion in 2025, at a compound annual growth rate (CAGR) of 20.1%. The expansion observed in the past can be linked to a greater need for immunology, a rise in collaborations, governmental initiatives, increased healthcare spending, and an increase in the number of healthcare facilities.
The microbiome market is expected to experience significant expansion in the upcoming years. Its valuation is projected to reach $1.43 billion by 2029, achieving a compound annual growth rate (CAGR) of 15.0%. This anticipated growth across the forecast period can be attributed to factors such as rising healthcare expenditures, an increasing need for personalized medicine, growing investment, technological advancements, and the escalating incidence of chronic diseases. Prominent trends for the forecast period include the integration of artificial intelligence, the formation of strategic collaborations and agreements, initiatives to boost revenues and establish market dominance, an increase in pipeline studies for developing microbiome therapeutics to address various diseases, considering investment in oncology microbiome therapeutics, and improvements in the productivity, efficiency, and accuracy of precision technologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3397&type=smp
Which Factors And Drivers Are Influencing The Microbiome Market In 2025?
The rising incidence of inflammatory bowel disease (IBD) is a significant driver for the future expansion of the microbiome market. IBD encompasses a set of long-term inflammatory conditions primarily impacting the gastrointestinal (GI) tract. This focus on inflammatory bowel disease has illuminated the critical role of the gut microbiome in its pathology, leading to a significant increase in research, diagnostic tools, and therapeutic interventions centered on the microbiome, thereby propelling the growth of the microbiome market. An example illustrating this trend is data from September 2022, where the American Gastroenterological Association (AGA), a US-based medical association of gastroenterologists, reported that 40% of Americans had to stop their daily routines due to uncomfortable bowel symptoms. Furthermore, 60-70 million Americans contend with gastrointestinal diseases that profoundly disrupt their daily existence. Thus, the escalating incidence of inflammatory bowel disease (IBD) is projected to stimulate the expansion of the microbiome market.
What Are The Key Segments In The Microbiome Market?
The microbiome market covered in this report is segmented –
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
What Trends Are Expected To Drive The Microbiome Market?
Increasing technological advancements represent a significant and expanding trend within the microbiome market. Leading firms within the microbiome industry are prioritizing the creation of sophisticated technological solutions pertaining to microbiomes. As an example, Seed, a recently established microbiome enterprise, launched its Probiotic and Prebiotic Daily Synbiotic, designed for both women and men. This Daily Synbiotic Seed stands out as the pioneer in employing a microbe-system approach, offering strain-specific benefits that extend beyond digestive wellness to include cardiac safety, skin health, immune regulation, reproductive well-being, gut barrier integrity, and combating oxidative stress.
Which Industry Leaders Are Driving Innovation Across The Microbiome Market?
Major companies operating in the microbiome market include Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Microbiome Market?
North America was the largest region in the microbiome market in 2024. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Microbiome Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3397&type=smp
Browse Through More Reports Similar to the Global Microbiome Market 2025, By The Business Research Company
Human Microbiome Therapeutics Market 2025
https://www.thebusinessresearchcompany.com/report/human-microbiome-therapeutics-market
Microbiome Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report
Crispr Technology Market 2025
https://www.thebusinessresearchcompany.com/report/crispr-technology-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
